Curvebeam AI Ltd. ASX: CVB Share Price & Review

CVB Overview

CVB Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

CVB Price Chart

Key Stats

Market Cap

n/a

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.14 - 0.55

Trade Value (12mth)

AU$10,622.00

1 week

-2.04%

1 month

41.18%

YTD

-39.24%

1 year

All time high

0.55

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

N/A

HALO Sector

Healthcare

Next Company Report Date

28-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

CVB Announcements

Latest Announcements

Date	Announcements
15 July 24	FDA clearance received for Enhanced HiRise × FDA clearance received for Enhanced HiRise
15 July 24	Updated Investor Presentation × Updated Investor Presentation
09 July 24	Sales Update for Q4 FY2024 × Sales Update for Q4 FY2024
04 July 24	Change in substantial holding - CVB in Itself × Change in substantial holding - CVB in Itself
03 July 24	Notification of cessation of securities - CVB × Notification of cessation of securities - CVB
24 June 24	Notification of cessation of securities - CVB × Notification of cessation of securities - CVB
24 June 24	Change of Director's Interest Notice - Greg Brown (CEO) × Change of Director's Interest Notice - Greg Brown (CEO)
17 June 24	Notification of cessation of securities - CVB × Notification of cessation of securities - CVB
12 June 24	Application for quotation of securities - CVB × Application for quotation of securities - CVB
05 June 24	Notice-Securities to be released from Escrow - 84,420 Shares × Notice-Securities to be released from Escrow - 84,420 Shares
31 May 24	Notification of cessation of securities - CVB × Notification of cessation of securities - CVB
16 May 24	Notice of Release from Voluntary Escrow × Notice of Release from Voluntary Escrow
08 May 24	Late Lodgement - App 3Y Change of Dirs Interest Notices × Late Lodgement - App 3Y Change of Dirs Interest Notices
08 May 24	Change of Director's Interest - Rob Lilley - Dir Fees × Change of Director's Interest - Rob Lilley - Dir Fees
08 May 24	Change of Director's Interest - Arun Singh - STI Share Right × Change of Director's Interest - Arun Singh - STI Share Right
08 May 24	Change of Director's Interest - Hashan De Silva - Dir Fees × Change of Director's Interest - Hashan De Silva - Dir Fees
08 May 24	Change of Director's Interest - Kate Robb - Dir Fees ZEPOs × Change of Director's Interest - Kate Robb - Dir Fees ZEPOs
30 April 24	Quarterly Activities/Appendix 4C Cash Flow Report × Quarterly Activities/Appendix 4C Cash Flow Report
30 April 24	Investor Presentation - Quarterly Update - Q3 FY24 × Investor Presentation - Quarterly Update - Q3 FY24
22 April 24	Notification of quarterly release date & webinar × Notification of quarterly release date & webinar
27 March 24	CVB Presenting at ASX Small & Mid Cap Conference × CVB Presenting at ASX Small & Mid Cap Conference
21 March 24	CVB Presentation for NWR Virtual Healthcare Conference × CVB Presentation for NWR Virtual Healthcare Conference
18 March 24	CVB to present at NWR Virtual Healthcare Conference × CVB to present at NWR Virtual Healthcare Conference
29 February 24	Appendix 4D - Interim Financial Report - Dec 2023 Half Year × Appendix 4D - Interim Financial Report - Dec 2023 Half Year
29 February 24	CVB - Commentary to App 4D - Dec 23 Half Year × CVB - Commentary to App 4D - Dec 23 Half Year

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Falling Divs over next 2

Values and Recommendations

Key Stats

Consensus Score

Recommendation

EPS 1 month Change

Quality Yield

Falling Divs over next 2

Halo Consensus Score

PEG Ratio

Consensus EPS Revisions

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

CVB Shortsell

Frequently Asked Questions

What is the current share price of Curvebeam AI Ltd. (CVB:ASX)?

The current share price of Curvebeam AI Ltd. (CVB:ASX) is AU$0.24.

What is the 52-week high share price for Curvebeam AI Ltd. (CVB:ASX)?

The 52-week high share price for Curvebeam AI Ltd. (CVB:ASX) is AU$0.55.

What is the 52-week low share price for Curvebeam AI Ltd. (CVB:ASX)?

The 52-week low share price for Curvebeam AI Ltd. (CVB:ASX)? is AU$0.14.

What is the dividend yield for Curvebeam AI Ltd. (CVB:ASX)?

Curvebeam AI Ltd. (CVB:ASX) does not pay a dividend.

What was Curvebeam AI Ltd. (CVB:ASX) last dividend payment?

Curvebeam AI Ltd. (CVB:ASX) does not pay a dividend.

What is the franking level for Curvebeam AI Ltd. (CVB:ASX)?

Curvebeam AI Ltd. (CVB:ASX) has a franking level of 0.0%.

In which sector is Curvebeam AI Ltd. (CVB:ASX) classified?

Curvebeam AI Ltd. (CVB:ASX) is classified in the Healthcare.

Company

Important

Get the latest insights and hot tips delivered right to your inbox

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.

CVB · ASX

Curvebeam AI Ltd. (ASX:CVB)

AU$0.24

CVB Overview

CVB Health Scores

CVB Price Chart

Key Stats

n/a

N/A

N/A

Dividends Overview

N/A

N/A

N/A

Market Data

Key Fundamentals

Other Data

CVB Announcements

Latest Announcements

FDA clearance received for Enhanced HiRise

Updated Investor Presentation

Sales Update for Q4 FY2024

Change in substantial holding - CVB in Itself

Notification of cessation of securities - CVB

Notification of cessation of securities - CVB

Change of Director's Interest Notice - Greg Brown (CEO)

Notification of cessation of securities - CVB

Application for quotation of securities - CVB

Notice-Securities to be released from Escrow - 84,420 Shares

Notification of cessation of securities - CVB

Notice of Release from Voluntary Escrow

Late Lodgement - App 3Y Change of Dirs Interest Notices

Change of Director's Interest - Rob Lilley - Dir Fees

Change of Director's Interest - Arun Singh - STI Share Right

Change of Director's Interest - Hashan De Silva - Dir Fees

Change of Director's Interest - Kate Robb - Dir Fees ZEPOs

Quarterly Activities/Appendix 4C Cash Flow Report

Investor Presentation - Quarterly Update - Q3 FY24

Notification of quarterly release date & webinar

CVB Presenting at ASX Small & Mid Cap Conference

CVB Presentation for NWR Virtual Healthcare Conference

CVB to present at NWR Virtual Healthcare Conference

Appendix 4D - Interim Financial Report - Dec 2023 Half Year

CVB - Commentary to App 4D - Dec 23 Half Year

Dividends

Key Stats

N/A

N/A

N/A

0.00%

Values and Recommendations

Key Stats

Halo Consensus Score

PEG Ratio

Consensus EPS Revisions

Short selling

Key Stats

0.00%

0

N/A

N/A

N/A

N/A

Discover Short-sellingOpportunities

CVB Shortsell

Related Companies

Frequently Asked Questions

Company

Company

Important

Discover
Short-selling
Opportunities